Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Replimune Group Inc
About REPL
Replimune Group, Inc. is a clinical-stage biotechnology company engaged in the development of novel oncolytic immunotherapies. Its proprietary RPx platform is based on a potent HSV-1 backbone intended to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The RPx platform is designed to have a unique dual local and systemic activity consisting of direct selective virus-mediated killing of the tumor resulting in the release of tumor-derived antigens and altering of the tumor microenvironment to ignite a systemic response. Its lead product candidate, RP1, is a selectively replicating version of HSV-1 that expresses GALV-GP R(-) and human GM-CSF. Its lead indication for its lead product candidate, RP1, is the potential treatment of advanced melanoma. Its pipeline product candidates include RP2 and RP3. It has designed its RP2 product candidate to express an anti-CTLA-4 antibody-like protein intended to block the inhibition of the immune response.
Find out what a historical investment in Replimune Group Inc would be worth today using our REPL stock calculator.
Market Capitalisation
$388.09M
Price-earnings ratio
-
Dividend yield
0.00%
Volume
6.04M
High today
$5.22
Low today
$4.70
Open price
$4.89
52-week high
$13.24
52-week low
$1.50
Ready to start your investing journey with Stake?
Open an accountHow do I buy REPL shares in Australia?
Buying REPL shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Replimune Group Inc in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in REPL
What is the ticker symbol of Replimune Group Inc?
The ticker symbol for Replimune Group Inc is REPL.
How much is one share of REPL?
One share of REPL is valued at $5.18 as of 20 May 2026.
What is the market capitalisation of Replimune Group Inc REPL?
As of 20 May 2026 Replimune Group Inc has a market cap of $388.09M.
What is the 52-week high for Replimune Group Inc stock?
The Replimune Group Inc 52-week high stock price is $13.24.
What is the 52-week low for Replimune Group Inc stock?
The Replimune Group Inc 52-week low stock price is $1.50.
Can I buy REPL shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy REPL shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in REPL on Stake
- Buy REPL from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of REPL from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
REPL related stocks